JP2004517100A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004517100A5 JP2004517100A5 JP2002551544A JP2002551544A JP2004517100A5 JP 2004517100 A5 JP2004517100 A5 JP 2004517100A5 JP 2002551544 A JP2002551544 A JP 2002551544A JP 2002551544 A JP2002551544 A JP 2002551544A JP 2004517100 A5 JP2004517100 A5 JP 2004517100A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- compound according
- trifluoromethylphenyl
- thiazol
- benzyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 4
- 101000741788 Homo sapiens Peroxisome proliferator-activated receptor alpha Proteins 0.000 claims 4
- 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 claims 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- SSDUSKOBZBGXRV-UHFFFAOYSA-N 2-methyl-2-[[3-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]methoxy]propanoic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C)=C1C(C)OC1=CC=CC(COC(C)(C)C(O)=O)=C1 SSDUSKOBZBGXRV-UHFFFAOYSA-N 0.000 claims 1
- YPDJBRIAQLVHSE-UHFFFAOYSA-N 2-methyl-2-[[3-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]propoxy]phenyl]methoxy]propanoic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C)=C1C(CC)OC1=CC=CC(COC(C)(C)C(O)=O)=C1 YPDJBRIAQLVHSE-UHFFFAOYSA-N 0.000 claims 1
- OQXJAKNLLGBCNA-UHFFFAOYSA-N 2-methyl-2-[[3-[2-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]propan-2-yloxy]phenyl]methoxy]propanoic acid Chemical compound CC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(C)(C)OC1=CC=CC(COC(C)(C)C(O)=O)=C1 OQXJAKNLLGBCNA-UHFFFAOYSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 1
- 208000022531 anorexia Diseases 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 206010061428 decreased appetite Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- UQIJWTDYTYTARD-UHFFFAOYSA-N ethyl 2-methyl-2-[[3-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]methoxy]propanoate Chemical compound CCOC(=O)C(C)(C)OCC1=CC=CC(OC(C)C2=C(N=C(S2)C=2C=CC(=CC=2)C(F)(F)F)C)=C1 UQIJWTDYTYTARD-UHFFFAOYSA-N 0.000 claims 1
- YLVIBAKEWWTIEB-UHFFFAOYSA-N ethyl 2-methyl-2-[[3-[2-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]propan-2-yloxy]phenyl]methoxy]propanoate Chemical compound CCOC(=O)C(C)(C)OCC1=CC=CC(OC(C)(C)C2=C(N=C(S2)C=2C=CC(=CC=2)C(F)(F)F)C)=C1 YLVIBAKEWWTIEB-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25707000P | 2000-12-20 | 2000-12-20 | |
| PCT/EP2001/014886 WO2002050047A1 (en) | 2000-12-20 | 2001-12-18 | Substitued oxazoles and thiazoles as hppar alpha agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004517100A JP2004517100A (ja) | 2004-06-10 |
| JP2004517100A5 true JP2004517100A5 (enExample) | 2005-12-22 |
Family
ID=22974753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002551544A Pending JP2004517100A (ja) | 2000-12-20 | 2001-12-18 | ｈＰＰＡＲアルファアゴニストとしての置換オキサゾールおよびチアゾール |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7091225B2 (enExample) |
| EP (1) | EP1345916A1 (enExample) |
| JP (1) | JP2004517100A (enExample) |
| AU (1) | AU2002233271A1 (enExample) |
| WO (1) | WO2002050047A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
| GB0113233D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
| GB0113232D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical process |
| HRP20040098B1 (en) * | 2001-08-13 | 2012-08-31 | Janssen Pharmaceutica N.V. | 2,4,5-TRlSUBSTITUTED THIAZOLYL DERIVATIVES AND THEIR ANTIINFLAMMATORY ACTIVITY |
| MXPA04003398A (es) * | 2001-10-12 | 2004-11-22 | Nippon Chemiphar Co | Activador para el receptor o activado con el proliferador de peroxisoma. |
| US6833380B2 (en) * | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
| US20030207924A1 (en) * | 2002-03-07 | 2003-11-06 | Xue-Min Cheng | Compounds that modulate PPAR activity and methods of preparation |
| KR100474202B1 (ko) * | 2002-05-04 | 2005-03-08 | 강헌중 | 티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체 |
| DK1554240T3 (da) * | 2002-10-21 | 2009-08-17 | Janssen Pharmaceutica Nv | Substituerede tetraliner og indaner og deres anvendelse |
| CA2503405A1 (en) * | 2002-10-21 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Treating syndrome x with substituted tetralins and indanes |
| EA009553B1 (ru) * | 2002-10-21 | 2008-02-28 | Янссен Фармацевтика Н.В. | Замещённые тетралины и инданы |
| US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| US6987118B2 (en) * | 2003-05-21 | 2006-01-17 | Pfizer Inc. | Tetrahydroisoquinoline derivatives as PPAR-alpha activators |
| JP2008510835A (ja) * | 2004-08-25 | 2008-04-10 | エッセンシャリス，インク． | カリウムａｔｐチャンネル開放因子の製剤処方、及びその使用 |
| WO2006071103A1 (en) * | 2004-12-31 | 2006-07-06 | Heonjoong Kang | Organoselenium containing compounds and their use |
| JP5191744B2 (ja) * | 2005-02-25 | 2013-05-08 | ソウル ナショナル ユニバーシティー インダストリー ファンデーション | ペルオキシソーム増殖子活性化受容体デルタリガンドのチアゾール誘導体及びその製造方法 |
| WO2007081521A2 (en) | 2006-01-05 | 2007-07-19 | Essentialis, Inc. | Salts of potassium atp channel openers and uses thereof |
| KR20090066289A (ko) | 2006-09-08 | 2009-06-23 | 로드아일랜드하스피틀 | 알코올 유발성 뇌 질환의 치료, 예방 및 역행 |
| CN101795691A (zh) * | 2007-07-02 | 2010-08-04 | 伊森舍丽斯有限公司 | 钾atp通道开放剂的盐及其用途 |
| WO2010099827A1 (en) * | 2009-03-05 | 2010-09-10 | Telecom Italia S.P.A. | Distributed system for storing digital data |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69941777D1 (de) * | 1998-03-10 | 2010-01-21 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
| GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| PE20011010A1 (es) | 1999-12-02 | 2001-10-18 | Glaxo Group Ltd | Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano |
| ES2257461T3 (es) * | 2000-12-21 | 2006-08-01 | Bristol-Myers Squibb Company | Inhibidores de tiazolilo de tirosina quinasas de la familia tec. |
-
2001
- 2001-12-18 JP JP2002551544A patent/JP2004517100A/ja active Pending
- 2001-12-18 WO PCT/EP2001/014886 patent/WO2002050047A1/en not_active Ceased
- 2001-12-18 US US10/451,298 patent/US7091225B2/en not_active Expired - Fee Related
- 2001-12-18 EP EP01984857A patent/EP1345916A1/en not_active Ceased
- 2001-12-18 AU AU2002233271A patent/AU2002233271A1/en not_active Abandoned